Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Carcinoma, Non-Small-Cell Lung 46Squamous Cell Carcinoma of Head and Neck 23Lung Neoplasms 22Oropharyngeal Neoplasms 13Urinary Bladder Neoplasms 12Nasopharyngeal Carcinoma 12Carcinoma 11Parkinson Disease 4, Autosomal Dominant Lewy Body 8Biliary Tract Neoplasms 8Uterine Cervical Neoplasms 7Head and Neck Neoplasms 7Pancreatic Neoplasms 6Neoplasms 6Esophageal Squamous Cell Carcinoma 6Colorectal Neoplasms 6Cholangiocarcinoma 6Small Cell Lung Carcinoma 5Neoplasm Metastasis 5Mouth Neoplasms 5Endometrial Neoplasms 5Stomach Neoplasms 4Laryngeal Neoplasms 4Esophageal Neoplasms 4Carcinoma, Squamous Cell 4Ovarian Neoplasms 3Neoplasms by Site 3Mesothelioma, Malignant 3Lymphoid Interstitial Pneumonia 3Hypopharyngeal Neoplasms 3Carcinoma, Transitional Cell 3

Interventions

pegylated granulocyte colony-stimulating factor 1pegfilgrastim 1merphos 1durvalumab 1Vinblastine 1Specimen Handling 1Platinum 1Methotrexate 1Magnetic Resonance Spectroscopy 1Immunoglobulin G 1Gemcitabine 1Doxorubicin 1Disulfides 1Cisplatin 1Biopsy 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Renal Pelvis and Ureter Urothelial Carcinoma × Cisplatin × 30 days × Clear all
NCT04628767 2026-06-03

Testing the Addition of MEDI4736 (Durvalumab) to Chemotherapy Before Surgery for Patients With High-Grade Upper Urinary Tract Cancer

National Cancer Institute (NCI)

Phase 2/3 Recruiting
131 enrolled
Genitourinary

Renal Pelvis and Ureter Urothelial Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡